Home > Healthcare > Medical Devices > Therapeutic Devices > Stents Market

Stents Market Share

Report ID: GMI3372
Published Date: Mar 2024
Report Format: PDF

Download Free Sample

Stents Market Share

Prominent players operating in the stents industry include Abbott Laboratories, B Braun Melsungen AG, Boston Scientific Corporation, among others. These industry players are noted to have undertaken certain strategic initiatives such as product launches and approvals assisting them to sustain the market competition. Ongoing advancements aim to improve stent design, durability, and biocompatibility while reducing risks of complications such as restenosis or thrombosis. Collaboration between medical professionals and device manufacturers drives innovation in this critical area of cardiovascular care.

Stents Market Companies

Some of the eminent market participants operating in the stents industry include:

Abbott Laboratories
B. Braun Melsungen AG
Biosensors International Group
Biotronik SE & Co. KG
Boston Scientific Corporation
Becton, Dickinson and Company
Elixir Medical Corporation
Medtronic Plc
Meril Life Science
MicroPort Scientific Corporation
Stryker Corporation
Terumo Corporation
Veryan Medical Limited
W.L Gore & Associates

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

Stents market accounted for revenues worth USD 9.4 billion in 2023, record 4.7% CAGR to reach USD 14.0 billion by 2032, attributed to increasing adoption of minimally invasive techniques and rising number of cardiovascular surgeries.

The vascular stent segment is anticipated to reach USD 13 billion by 2032, driven by the growing burden of coronary artery disease and technological advancements for development of advanced product.

North America stents industry accounted for USD 2.1 billion in 2023 and is projected to record impressive growth through 2032, owing to high prevalence of cardiovascular diseases, such as coronary artery disease and peripheral artery disease.

Abbott Laboratories, B. Braun Melsungen AG, Biosensors International Group, Biotronik SE & Co. KG, Boston Scientific Corporation, Becton, Dickinson and Company, Elixir Medical Corporation, Medtronic Plc, Meril Life Science, MicroPort Scientific Corporation, and Stryker Corporation.